Cargando…
Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series
Immunocompromised patients with B-cell deficiencies are at risk for prolonged symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We describe 4 patients treated for B-cell malignancies with B-cell-depleting therapies who developed persistent SARS-CoV-2 infection and h...
Autores principales: | Breeden, Madison, Aitken, Samuel L, Baang, Ji Hoon, Gravelin, Misty, Kaul, Daniel R, Lauring, Adam S, Petty, Lindsay A, Gregg, Kevin S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114524/ https://www.ncbi.nlm.nih.gov/pubmed/37089775 http://dx.doi.org/10.1093/ofid/ofad189 |
Ejemplares similares
-
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Nirmatrelvir Plus Ritonavir: First Approval
por: Lamb, Yvette N.
Publicado: (2022) -
Post nirmatrelvir/ritonavir erythema multiforme in a patient with coronavirus disease infection
por: Tavares-Júnior, José Wagner Leonel, et al.
Publicado: (2023) -
Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis
por: Savinkina, Alexandra, et al.
Publicado: (2022)